Dr. James Campbell, MD, MS
James Campbell, MD, MS, Professor of Paediatrics and a paediatric infectious disease specialist at the University of Maryland School of Medicine, where he conducts important vaccine research.
Dr. Campbell, who has been on faculty at the University of Maryland School of Medicine since 2001, previously worked in Uganda for the , mainly in the field of HIV prevention and care. Since 2012, he has been Vice Chair of the Institutional Review Board and Associate Director of the University of Maryland Baltimore Clinical Research Training and Mentoring Program. He is a member of the Committee on Infectious Diseases (COID or “Red Book Committee”) for the American Academy of Paediatrics. Dr. Campbell is in charge of several clinical research studies being conducted in the Center for Vaccine Development and Global Health (CVD), involving the testing of paediatric vaccines. He is an expert on vaccine-preventable diseases such as measles.
Dr. Ann Marie Chiasson, MD, MPH
Ann Marie Chiasson, MD, MPH is the Director of the Fellowship at the University of Arizona Andrew Weil Center for Integrative Medicine and an Associate Professor of Clinical Medicine at the University of Arizona. She is board-certified in Family Medicine, Integrative Medicine and Hospice and Palliative Medicine. She also earned a Master’s in Public Health from Johns Hopkins Bloomberg School of Health and an MD with honours from Dalhousie School of Medicine. She currently serves as the Chair of the American Board of Integrative Medicine.
Dr. Maire Connolly
Dr. Connolly graduated in medicine from NUIG, holds a Master’s in Public Health from UCD, has a Diploma in Tropical Medicine from the London School of Hygiene and Tropical Medicine and is a member of the Faculty of Public Health Medicine of Ireland. Her areas of expertise include global health security, emerging infectious diseases, pandemic management and humanitarian response. She coordinated a Horizon 2020 project on pandemic management in the School of Medicine at NUIG from 2015-2017 and is principal investigator of the phase 2 project on pandemic preparedness and response since Feb 2021. She is currently public health adviser to the Department of Health in Ireland on the COVID-19 response and member of the Expert Advisory Group (EAG) to the National Public Health Emergency Team (NPHET). She is also a member of the Irish Epidemiological Modelling Advisory Group (IEMAG) to NPHET chaired by Prof Philip Nolan, President of Maynooth University.
Dr. Connolly worked with the World Health Organisation in Geneva from 1995 to 2012 were she was policy advisor to WHO’s Assistant Director-General for Health Security and lead focal point for pandemic preparedness from 2007 to 2012. Prior to that she was WHO’s Coordinator for Disease Control in Emergencies from 2000 to 2007. She has worked on UN response teams in over 20 countries including Afghanistan, Kosovo, Iraq, Iran, Gaza, East Timor, Uganda and most recently Jordan as part of WHO’s Syrian crisis response. Dr. Connolly has peer-reviewed publications in journals such as The Lancet and Emerging Infectious Diseases and has published a number of books on communicable diseases in emergencies.
Dr. Mohammed Lamorde
Dr. Mohammed Lamorde is Head of the Global Health Security Programme at the Infectious Diseases Institute, College of Health Sciences, Makerere University , Uganda. He is an internal medicine physician trained in Nigeria, United Kingdom and the Republic of Ireland. He is a member of the Royal College of Physicians of the United Kingdom.
Over the past nine years he has worked at IDI, undertaking clinical research in the fields of HIV, tuberculosis and malaria, as well as health economics evaluations for interventions relevant to public health in developing countries. Dr. Lamorde has also been a clinician facilitator for district-level training in management of medical emergencies and infection prevention and control for emerging infectious diseases.
In 2012, he was awarded a PhD at Trinity College Dublin, Ireland in recognition of his work on the clinical pharmacokinetics of medicines used in the management of HIV-infected adults. He subsequently held post-doctoral positions at IDI including a Sewankambo Post-Doctoral Scholarship focusing on the effect of food on the pharmacokinetics of rilpivirine, and a Senior Fellowship awarded by the European and Developing Countries Clinical Trials Partnership to study drug-drug interactions between rifampicin-based antituberculosis and antimalarial drugs among Ugandan patients with tuberculosis.
Dr. Lamorde is the President of the International Society for Pharmacoeconomics and Outcomes Research Uganda Chapter; and he is a member of the advisory panel of the leading international HIV drug-drug interactions website www.hiv-druginteractions.org and of the African Research Network for Neglected Tropical Diseases.
Dr. Yukari C. Manabe, MD
Dr. Manabe is a Professor of Medicine, Department of Medicine, Division of Infectious Diseases within the Johns Hopkins University School of Medicine with joint appointments in the Johns Hopkins Bloomberg School of Public Health Departments of International Health and Molecular Microbiology and Immunology and the Associate Director of Global Health Research and Innovation within the Johns Hopkins Center for Global Health. As the Director of the new Center for Innovative Diagnostics for Infectious Diseases, she is dedicated to accelerating infectious disease diagnostic development and particularly frugal innovation for rapid and point-of-care to increase diagnostic certainty and targeted treatment. Her research has focused on infectious disease diagnostics for HIV, TB, STI’s, and respiratory viruses (COVID-19, influenza) and their impact on patient-centered outcomes.
Dr. Manabe is an author of more than 230 peer-reviewed publications. She obtained her undergraduate degree from Yale University and her MD from Columbia University College of Physicians and Surgeons. She joined the Johns Hopkins School of Medicine faculty in 1999 after completing her residency in internal medicine and fellowship in infectious diseases at Johns Hopkins Hospital.